@incollection{,
	
					
					
					3D120B4E0BD7027C1AA16CD34D5E39A8
				,
	author={{AwadMagbri} and {Dialysis Access Center of Pittsburgh}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1621114
}

@incollection{b0,
	
	
		,
	title={{Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey}}
		,
	author={{
			CAJones
		} and {
			GMMcquillan
		} and {
			JWKusek
		}}
		
		
	
	
		,
	journal={{Am J Kidney Dis}}
		
			32
			
			,
	year={1998}
		
	

}

@incollection{b1,
	
	
		,
	title={{Kidney Disease Outcome Quality Initiative (K/DOQI), Advisory Board. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification}}
	
	
		,
	journal={{Am J Kidney Dise}}
		
			39
			2
			,
	year={2002}
		
		
			National Kidney Foundation (NKF)
		
	
	,
	note={Suppl 2) S-249}

}

@incollection{b2,
	
	
		,
	title={{Early chronic kidney disease-mineral bone disorder stimulates vascular calcification}}
		,
	author={{
			YFang
		} and {
			CGinsberg
		} and {
			TSugatani
		}}
		
		
	
	
		,
	journal={{Kidney Int}}
		
			142
			,
	year={2014}
		
	

}

@book{b3,
	
	
		,
	title={{Pttren of FGF-23, DMPI, and MEPE expression in patients with chronic kidney disease Bone}}
		,
	author={{
			RCPereira
		} and {
			HJuppner
		} and {
			Azucena-Serrano
		} and {
			CE
		}}
		
		
		
		
			,
	year={2009}
			45
			1161
		
	

}

@incollection{b4,
	
	
		,
	title={{Repression of osteocyte Wnt/B-catenin signaling is as early event in the progression of renal osteodystrophy}}
		,
	author={{
			YSabbagh
		} and {
			FGGraciolli
		} and {
			SO'brien
		}}
		
		
	
	
		,
	journal={{J Bone Miner Res}}
		
			27
			175
			,
	year={2012}
		
	

}

@incollection{b5,
	
	
		,
	title={{Early control of PTH and FGF-23 in nonmorphosphatemic CKD patients a new target in CKD-MBD therapy?}}
		,
	author={{
			RBOliveira
		} and {
			ALCancela
		} and {
			FGGraciolli
		}}
		
		
	
	
		,
	journal={{Cli J AM SocNephrol}}
		
			5
			286
			,
	year={2010}
		
	

}

@incollection{b6,
	
	
		,
	title={{Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disase}}
		,
	author={{
			TIsakova
		} and {
			PWahl
		} and {
			GSVargas
		}}
		
		
	
	
		,
	journal={{Kidney Int}}
		
			79
			1370
			,
	year={2011}
		
	

}

@incollection{b7,
	
	
		,
	title={{Fibroblast growth factor-23 mitigate hyperphosphatemia but accentuate calcitriol deficiency in chronic kidney disease}}
		,
	author={{
			OGutierrez
		} and {
			TIsakova
		} and {
			ERhee
		}}
		
		
	
	
		,
	journal={{J AM SocNephrol}}
		
			16
			2205
			,
	year={2005}
		
	

}

@incollection{b8,
	
	
		,
	title={{Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options}}
		,
	author={{
			JCunningham
		} and {
			FLocatelli
		} and {
			MRodriguez
		}}
		
		
	
	
		,
	journal={{Cli J AM SocNephrol}}
		
			6
			913
			,
	year={2011}
		
	

}

@incollection{b9,
	
	
		,
	title={{Prevelance of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease}}
		,
	author={{
			ALevin
		} and {
			GLBakris
		} and {
			MMolitch
		}}
		
		
	
	
		,
	journal={{KidenyInt}}
		
			71
			31
			,
	year={2007}
		
	

}

@incollection{b10,
	
	
		,
	title={{Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure}}
		,
	author={{
			TOPitts
		} and {
			BHPiraino
		} and {
			RMitro
		}}
		
		
	
	
		,
	journal={{J Clin Endocrinol Metabolism}}
		
			67
			876
			,
	year={1988}
		
	

}

@incollection{b11,
	
	
		,
	title={{Metabolic bone disease in chronic kidney disease}}
		,
	author={{
			KJMartin
		} and {
			EAGonzalez
		}}
		
	
	
		,
	journal={{J AM Soc Nephrol}}
		
			18
			875
			,
	year={2007}
		
	

}

@incollection{b12,
	
	
		,
	title={{Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure}}
		,
	author={{
			DMKates
		} and {
			DJSherrard
		} and {
			DLAndress
		}}
		
		
	
	
		,
	journal={{AM J Kidney Dis}}
		
			30
			809
			,
	year={1997}
		
	

}

@incollection{b13,
	
	
		,
	title={{Renal osteodystrophy}}
		,
	author={{
			KAHruska
		} and {
			SLTeitelbaum
		}}
		
	
	
		,
	journal={{N Engl J Med}}
		
			333
			166
			,
	year={1995}
		
	

}

@incollection{b14,
	
	
		,
	title={{Use of alkaline calcium salts as phosphate binder in uremic patients}}
		,
	author={{
			AFournier
		} and {
			PMoriniere
		} and {
			BenHamida
		} and {
			F
		}}
		
		
		
	
	
		,
	journal={{Kidney IntSuppl}}
		
			38
			S50
			,
	year={1992}
		
	

}

@incollection{b15,
	
	
		,
	title={{Secondary hyperparathyroidism in renal failure; The trade-off hypothesis revisited}}
		,
	author={{
			FLiach
		}}
	
	
		,
	journal={{Am J Kidney Disease}}
		
			25
			663
			,
	year={1995}
		
	

}

@incollection{b16,
	
	
		,
	title={{Cellular and molecular mechanisms of secondary hyperparathyroidism}}
		,
	author={{
			JSilver
		} and {
			RLevi
		}}
		
	
	
		,
	journal={{Clin Nephrol}}
		
			63
			119
			,
	year={2005}
		
	

}

@incollection{b17,
	
	
		,
	title={{Effects of cinacalcet and concurrent low dose vitamin D on FGF23 levels in ESRD}}
		,
	author={{
			JBWetmore
		} and {
			SLiu
		} and {
			RKrebill
		}}
		
		
	
	
		,
	journal={{Clin J AM Nephrol}}
		
			5
			110
			,
	year={2010}
		
	

}

@incollection{b18,
	
	
		,
	title={{Circulating FGF-23 is regulated by 1 alpha, 25 dihydroxyvitamin D3 and phosphorus in vivo}}
		,
	author={{
			HSaito
		} and {
			AMaeda
		} and {
			SOhtomo
		}}
		
		
	
	
		,
	journal={{J Biol Chem}}
		
			280
			2543
			,
	year={2005}
		
	

}

@incollection{b19,
	
	
		,
	title={{Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease}}
		,
	author={{
			KGKoenig
		} and {
			JSLindberg
		} and {
			JEZerwekh
		}}
		
		
	
	
		,
	journal={{Kidney Int}}
		
			41
			161
			,
	year={1992}
		
	

}

@incollection{b20,
	
	
		,
	title={{Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D}}
		,
	author={{
			LWilson
		} and {
			AFelsenfeld
		} and {
			MKDrezner
		} and {
			FLiach
		}}
		
		
		
	
	
		,
	journal={{Kidney Int}}
		
			27
			565
			,
	year={1985}
		
	

}

@incollection{b21,
	
	
		,
	title={{Prevalence and severity of disordered mineral metabolism in blacks with chronic kidney disease}}
		,
	author={{
			OMGutierrez
		} and {
			TIsakova
		} and {
			DLAndress
		}}
		
		
	
	
		,
	journal={{Kidney Int}}
		
			956
			,
	year={2008}
		
	

}

@incollection{b22,
	
	
		,
	title={{The biological action of calcitriol in renal failure}}
		,
	author={{
			CHHsu
		} and {
			SRPatel
		} and {
			EWYoung
		} and {
			RVanholder
		}}
		
		
		
	
	
		,
	journal={{Kidney Int}}
		
			46
			605
			,
	year={1994}
		
	

}

@incollection{b23,
	
	
		,
	title={{Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat}}
		,
	author={{
			JSilver
		} and {
			TNaveh-Many
		} and {
			HMayer
		}}
		
		
	
	
		,
	journal={{J Clin Invest}}
		
			78
			1296
			,
	year={1986}
		
	

}

@incollection{b24,
	
	
		,
	title={{Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure}}
		,
	author={{
			HHMalluche
		} and {
			HMawad
		} and {
			NJKoszewski
		}}
		
		
	
	
		,
	journal={{Kidney Int}}
		
			62
			367
			,
	year={2002}
		
	

}

@incollection{b25,
	
	
		,
	title={{Cytoplasmic and nuclear binding components for 1-alpha 25-dihydroxyvitamin D3 in chick parathyroid glands}}
		,
	author={{
			PFBrumbaugh
		} and {
			MRHughes
		} and {
			MRHaussler
		}}
		
		
		1975: 72: 4871
	
	
		,
	journal={{Proc Natl Acad Sci}}
		
	

}

@incollection{b26,
	
	
		,
	title={{1,25-dihydroxyvitamin D3 and 22-oxacacitriol revent the decrease in vitamin D receptor content in parathyroid glands of uremic rats}}
		,
	author={{
			MDenda
		} and {
			JFinch
		} and {
			AJBrown
		}}
		
		
	
	
		,
	journal={{Kidney Int}}
		
			50
			34
			,
	year={1996}
		
	

}

@incollection{b27,
	
	
		,
	title={{Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients}}
		,
	author={{
			ESlatopolsky
		} and {
			CWeerts
		} and {
			JThielan
		}}
		
		
	
	
		,
	journal={{J ClinInvest}}
		
			74
			2136
			,
	year={1984}
		
	

}

@incollection{b28,
	
	
		,
	title={{Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients}}
		,
	author={{
			NFukuda
		} and {
			HTanaka
		} and {
			YTominaga
		}}
		
		
	
	
		,
	journal={{J Clin Invest}}
		
			92
			1436
			,
	year={1993}
		
	

}

@incollection{b29,
	
	
		,
	title={{The calciumsensing receptor: a key in the pathogenesis of secondary hyperparathyroidism}}
		,
	author={{
			MRodriguez
		} and {
			ENemeth
		} and {
			DMartin
		}}
		
		
		288: F253
	
	
		,
	journal={{Am J Physiol Renal Physiol}}
		
			,
	year={2005}
		
	

}

@incollection{b30,
	
	
		,
	title={{Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice}}
		,
	author={{
			YCLi
		} and {
			MAmling
		} and {
			AEPirro
		}}
		
		
	
	
		,
	journal={{Endocrinology}}
		
			139
			4391
			,
	year={1998}
		
	

}

@incollection{b31,
	
	
		,
	title={{Inactivation of the 25-hydroxyvitamin D 1-alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis}}
		,
	author={{
			DKPanda
		} and {
			DMiao
		} and {
			IBolivar
		}}
		
		
	
	
		,
	journal={{J BiolChem}}
		
			16754
			,
	year={2004}
		
	

}